Skip to search formSkip to main contentSkip to account menu

Triton WR-1339

Known as: WR-1339, triton WR 1339 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
The aim of this study was to investigate the hypolipidemic effect of the total flavonoids from mulberry leaves (MTF) in… 
Highly Cited
2002
Highly Cited
2002
1981
1981
The characteristics of lipoprotein lipolytic activity in lysosomes after the administration of Triton WR-1339 were studied, and… 
Highly Cited
1980
Highly Cited
1980
The effects of Triton WR-1339 and phenobarbital on ethinyl estradiol bile secretory failure were examined to determine the… 
Highly Cited
1979
Highly Cited
1979
Changes in whole plasma and lipoprotien apoprotein concentrations were determined after a single injection of Triton WR 1339 into… 
Highly Cited
1978
Highly Cited
1978
RATS TREATED WITH ETHYNYLOESTRADIOL HAVE MARKED HYPOLIPIDAEMIA: serum cholesterol is decreased to 5%, triacylglycerol to 10% and… 
Highly Cited
1976
Highly Cited
1976
1. Lipoprotein lipase activity was measured in heart homogenates and in heparin-releasable and non-releasable fractions of… 
Highly Cited
1967
Highly Cited
1967
1. The initial rate of removal from the circulation of injected [14C] labelled chylomicron triglyceride is much slower in rats… 
Highly Cited
1957
Highly Cited
1957
Sequential changes in the plasma lipids of rats injected with Triton were studied. It was observed that following a dose of… 
Highly Cited
1953
Highly Cited
1953
Injection of triton WR-1339 into rats leads to a rapid increase in the cholesterol, cholate, and various lipid fractions of their…